Chimeric rat/human HER2 efficiently circumvents HER2 tolerance in cancer patients.
Occhipinti S, Sponton L, Rolla S, Caorsi C, Novarino A, Donadio M, Bustreo S, Satolli MA, Pecchioni C, Marchini C, Amici A, Cavallo F, Cappello P, Pierobon D, Novelli F, Giovarelli M.
Occhipinti S, et al. Among authors: novelli f.
Clin Cancer Res. 2014 Jun 1;20(11):2910-21. doi: 10.1158/1078-0432.CCR-13-2663. Epub 2014 Mar 25.
Clin Cancer Res. 2014.
PMID: 24668647
Free article.